Bausch Health Companies Inc.
As of Oct 23, 2026 close
- Market cap
- $2.43B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $4.33$8.00
- Volume (live)
- -
- Avg. volume (3M)
- 1.94M
Bausch Health Companies (BHC) Stock Price & Financial Analysis
Bausch Health Companies Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $6.20 - $6.49 |
|---|---|
| 52-Week High | $8.00 |
| 52-Week Low | $4.33 |
| Open | $6.44 |
| Volume (last close) | 2.43M |
| Average Volume (3M) | 1.94M |
| Revenue (TTM) | 10.74B |
|---|---|
| Net Income (TTM) | -1.08B |
| Free Cash Flow (TTM) | 1.43B |
| EPS (TTM) | −$2.89 |
| Profit Margin | -10.07% |
| Operating Margin | 25.45% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Last Dividend Ex-Date | Nov 10, 2010 |
| Market Cap | 2.43B |
|---|---|
| Shares Outstanding | 378.10M |
| Price to Sales (P/S) | 0.23 |
| Price to Book (P/B) | -3.04 |
| EV/EBITDA | 6.09 |
| 50-Day MA | $6.16 |
|---|---|
| 200-Day MA | $5.72 |
| 1-Year Change | +1.72% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Bausch Health Companies at a Glance
As of the Oct 23, 2026 close, Bausch Health Companies (BHC) has a market capitalization of $2.43B. The stock trades at 0.2× sales. Over the trailing twelve months it lost $1.08B on revenue of $10.74B and generated $1.43B of free cash flow. Revenue grew 9.7% year over year.
As of its latest reported balance sheet, it holds $1.82B in cash and securities against $20.74B of debt, a net debt position of $18.92B.
Bausch Health Companies does not currently pay a dividend.
The share price is up 1.7% over the past year. At $6.44 (the Oct 23, 2026 close) it sits within its 52-week range of $4.33 to $8.00, above its 200-day moving average of $5.72.
Based on 3 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $9.00, 39.8% above the Oct 23, 2026 close.
Frequently Asked Questions About Bausch Health Companies
What is the current stock price for BHC?
As of the Oct 23, 2026 close, BHC stock trades at $6.44. The 52-week range is $4.33–$8.00, with a day range of $6.20–$6.49.
What is the P/E ratio for BHC?
The P/E ratio (Price-to-Earnings) for BHC is shown in the Key Statistics section. This valuation metric helps compare Bausch Health Companies Inc. to industry peers.
Does BHC pay dividends?
Bausch Health Companies does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for BHC?
Based on ratings from 3 professional analysts over the last 90 days, the consensus for BHC is Buy. The average 12-month price target is $9.00, a 39.8% upside from the Oct 23, 2026 close of $6.44.
What is the market cap of BHC?
As of the Oct 23, 2026 close, Bausch Health Companies's market capitalization is $2.43B, classifying it as a mid-cap company. Bausch Health Companies operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.